Stockreport

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF CAMBRIDGE, Mass. March 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on develo [Read more]